The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2017

Filed:

Jun. 15, 2015
Applicant:

Pharmain Corporation, Bothell, WA (US);

Inventors:

Gerardo M. Castillo, Bothell, WA (US);

Elijah Bolotin, Bothell, WA (US);

Assignee:

PHARMAIN CORPORATION, Bothell, WA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 17/06 (2006.01); C07K 14/575 (2006.01); A61K 47/48 (2006.01); C07K 7/16 (2006.01); C07K 14/485 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/57563 (2013.01); A61K 47/48038 (2013.01); C07K 7/16 (2013.01); C07K 14/485 (2013.01); C07K 14/575 (2013.01); A61K 38/00 (2013.01);
Abstract

The invention describes compositions of peptide analogs that are active in blood or cleavable in blood to release an active peptide. The peptide analogs have a general formula: A-(Cm)-Peptide (SEQ ID NO: 76), wherein A is hydrophobic moiety or a metal binding moiety, e.g., a chemical group or moiety containing 1) an alkyl group having 6 to 36 carbon units, 2) a nitrilotriacetic acid group, 3) an imidiodacetic acid group, or 4) a moiety of formula (ZHis)(SEQ ID NO: 50), wherein Z is any amino acid residue other than histidine, His is histidine, y is an integer from 0-6; w is an integer from 1-6; and p is an integer from 1-6; wherein if A has alkyl group with 6 to 36 carbon units x is greater than 0; and Cm is a cleavable moiety consisting of glycine or alanine or lysine or arginine or N-Arginine or N-lysine, wherein x is an integer between 0-6 and N may be any amino acid or none. The peptide analogs are complexed with polymeric carrier to provide enhanced half-life.


Find Patent Forward Citations

Loading…